Cancer genome instability arises from diverse defects in DNA-repair machinery, which make cancer cells more susceptible to DNA targeting agents. The interrelation between DNA …
Rationale: Accumulating evidence demonstrated that long noncoding RNAs (lncRNAs) involved in the regulation of the immune system and displayed a cell-type-specific pattern in …
H Zhang, N Zhang, W Wu, R Zhou, S Li… - Briefings in …, 2022 - academic.oup.com
Long noncoding ribonucleic acids (RNAs; lncRNAs) have been associated with cancer immunity regulation. However, the roles of immune cell-specific lncRNAs in glioblastoma …
N Zhang, H Zhang, Z Liu, Z Dai, W Wu, R Zhou… - Cell …, 2023 - Wiley Online Library
The immune cells play an increasingly vital role in influencing the proliferation, progression, and metastasis of lung adenocarcinoma (LUAD) cells. However, the potential of immune …
M Ababou - Molecular genetics and metabolism, 2021 - Elsevier
Autosomal hereditary recessive diseases characterized by genetic instability are often associated with cancer predisposition. Bloom syndrome (BS), a rare genetic disorder, with< …
Y Chen, A Geng, W Zhang, Z Qian, X Wan… - Ageing Research …, 2020 - Elsevier
DNA carries the genetic information that directs complex biological processes; thus, maintaining a stable genome is critical for individual growth and development and for …
S Park, H Lee, B Lee, SH Lee, JM Sun, WY Park… - Journal of Thoracic …, 2019 - Elsevier
Introduction Impairment in DNA damage response and repair (DDR) pathway is known as a predictive biomarker of platinum sensitivity. Recently, DDR alteration is re-emphasized as a …
N Gupta, TT Huang, JR Nair, D An, G Zurcher… - Science translational …, 2023 - science.org
Poly (ADP-ribose) polymerase inhibitors (PARPis) have changed the treatment paradigm in breast cancer gene (BRCA)–mutant high-grade serous ovarian carcinoma (HGSC) …
Simple Summary Chemotherapeutic DNA-damaging agents targeting replication are widely used but predictive rationales for drug combinations and patient selection still need clinical …